Cypher clarification
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson/Cordis' Cypher drug-eluting coronary stent uses sirolimus (Rapamune), licensed from Wyeth and bound to the stent using SurModics' coating technology and related reagents. "The Gray Sheet" had incorrectly stated that the Cypher uses paclitaxel (1"The Gray Sheet" Jan. 6, 2003, p. 3)...